The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

The complement system is well known for its role in innate immunity and in maintenance of
tissue homeostasis, providing a first line of defence against infection and playing a key role in …

Complement is involved in developmental synaptic pruning and pathological synapse loss
in Alzheimer’s disease. It is posited that C1 binding initiates complement activation on …

Conclusions The main features of respiratory mechanics, the response to treatment (such as
the oxygenation response to LRMs or prone position), and prognosis are similar in COVID-…

Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening disease
occurring several weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Complement, a critical defence against pathogens, has been implicated as a driver of pathology
in COVID‐19. Complement activation products are detected in plasma and tissues and …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus was identified in
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the world, …

Evidence implicating complement in neuroinflammatory and neurodegenerative diseases (NDDs)
has accumulated over the past decade, revealing complement as a driver of …

Background Serological assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
have roles in seroepidemiology, convalescent plasma-testing, antibody durability …

Accurate assessment of SARS‐CoV‐2 immunity is critical in evaluating vaccine efficacy and
devising public health policies. Whilst the exact nature of effective immunity remains …